S. 146 · 118th Congress
Cap Insulin Prices Act
- Stage
- In committee
- Sponsor
- Josh Hawley
- Introduced
- 2023-01-30
- Latest action
- 2024-06-12 · Committee on Banking, Housing, and Urban Affairs. Hearings held.
Summary
Cap Insulin Prices Act
This bill reduces cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $25 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.
The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply insulin products at $25 beginning in 2024. The current cap on insulin products under Medicare is $35 per month.